Antagonists of human gamma interferon

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/57 (2006.01) A61K 38/21 (2006.01) A61K 39/395 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 16/24 (2006.01) C07K 16/42 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2092541

2092541 9206115 PCTABS00011 Novel synthetic polypeptides having amino acid sequences corresponding to the sequence of one or more specific regions of human gamma interferon are provided by this invention. These polypeptides specifically inhibit the binding of human gamma interferon to cellular receptors and the biological activity of such interferon. Antibody antagonists of the binding of human gamma interferon to cellular receptors based upon the use of the polypeptides as antigens are also provided. Some of these antagonists bind to specific regions of gamma interferon which are believed to be involved in interactions between the interferon and its receptors. Other antibody antagonists are anti-idiotypic antibodies which appear to compete directly with gamma interferon for binding to the cellular receptors. Also provided are methods for the use of the polypeptides and antibodies as inhibitors of the binding of gamma interferon to its cellular receptors.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antagonists of human gamma interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonists of human gamma interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of human gamma interferon will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1641944

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.